AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells

被引:90
作者
Jacobs-Helber, SM
Wickrema, A
Birrer, MJ
Sawyer, ST
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol Toxicol, Richmond, VA 23298 USA
[2] Univ Illinois, Hematol Oncol Sect, Chicago, IL 60607 USA
[3] NCI, Dept Cell & Canc Biol, Med Branch, NIH, Rockville, MD 20850 USA
关键词
D O I
10.1128/MCB.18.7.3699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor AP1 has been implicated in the induction of apoptosis in cells in response to stress factors and growth factor withdrawal. We report here that AP1 is necessary for the induction of apoptosis following hormone withdrawal in the erythropoietin (EPO)-dependent erythroid cell line HCD57. AP1 DNA binding activity increased upon withdrawal of HCD57 cells from EPO. A dominant negative AP1 mutant rendered these cells resistant to apoptosis induced by EPO withdrawal and blocked the downregulation of Bcl-X-L. JunB is a major binding protein in the API complex observed upon EPO withdrawal; JunB but not c-Jun was present in the AP1 complex 3 h after EPO withdrawal in HCD57 cells, with a concurrent increase in junB message and protein. Furthermore, analysis of API DNA binding activity in an apoptosis-resistant subclone of HCD57 revealed a lack of induction in AP1 DNA binding activity and no change in junB mRNA levels upon EPO withdrawal. In addition, we determined that c-Jun and AP1 activities correlated with EPO-induced proliferation and/or protection from apoptosis. AP1 DNA binding activity increased over the first 3 h following EPO stimulation of HCD57 cells, and suppression of AP1 activity partially inhibited EPO-induced proliferation. c-Jun but not JunB was present in the AP1 complex 3 h after EPO addition. These results implicate AP1 in the regulation of proliferation and survival of erythroid cells and suggest that different API factors may play distinct roles in both triggering apoptosis (JunB) and protecting erythroid cells from apoptosis (c-Jun).
引用
收藏
页码:3699 / 3707
页数:9
相关论文
共 75 条
  • [1] INDUCTION OF JUNB EXPRESSION, BUT NOT C-JUN, BY GRANULOCYTE COLONY-STIMULATING FACTOR OR MACROPHAGE COLONY-STIMULATING FACTOR IN THE PROLIFERATIVE RESPONSE OF HUMAN MYELOID-LEUKEMIA CELLS
    ADACHI, K
    SAITO, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) : 1657 - 1661
  • [2] ADLER V, 1995, CELL GROWTH DIFFER, V6, P1437
  • [3] THE TRANSACTIVATING DOMAIN OF THE C-JUN PROTO-ONCOPROTEIN IS REQUIRED FOR COTRANSFORMATION OF RAT EMBRYO CELLS
    ALANI, R
    BROWN, P
    BINETRUY, B
    DOSAKA, H
    ROSENBERG, RK
    ANGEL, P
    KARIN, M
    BIRRER, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (12) : 6286 - 6295
  • [4] ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1
    ANGEL, P
    ALLEGRETTO, EA
    OKINO, ST
    HATTORI, K
    BOYLE, WJ
    HUNTER, T
    KARIN, M
    [J]. NATURE, 1988, 332 (6160) : 166 - 171
  • [5] PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR
    ANGEL, P
    IMAGAWA, M
    CHIU, R
    STEIN, B
    IMBRA, RJ
    RAHMSDORF, HJ
    JONAT, C
    HERRLICH, P
    KARIN, M
    [J]. CELL, 1987, 49 (06) : 729 - 739
  • [6] Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes
    Assefa, Z
    Garmyn, M
    Bouillon, R
    Merlevede, W
    Vandenheede, JR
    Agostinis, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (06) : 886 - 891
  • [7] Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling
    Atfi, A
    Djelloul, S
    Chastre, E
    Davis, RR
    Gespach, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1429 - 1432
  • [8] Induction of apoptosis by the transcription factor c-Jun
    BossyWetzel, E
    Bakiri, L
    Yaniv, M
    [J]. EMBO JOURNAL, 1997, 16 (07) : 1695 - 1709
  • [9] BROWN PH, 1994, ONCOGENE, V9, P791
  • [10] BROWN PH, 1993, ONCOGENE, V8, P877